IP Library Granted Patent US 7,429,647
Granted Patent B2
US 7,429,647 · App. 11/333,197 · Granted Sep 30, 2008

Polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,429,647
App. No.
11/333,197
Granted
Sep 30, 2008
Kind
B2
Abstract

Polypeptides capable of forming antigen binding structures specific for Rhesus D antigens include the sequences indicated in the FIGS. 1 a to 16 b . The obtained polypeptides, being Fab fragments, MAY be used directly as an active ingredient in pharmaceutical and diagnostic compositions. The Fab and their DNA sequences can also be used for the preparation of complete recombinant Anti-Rhesus D antibodies. Useful in pharmaceutical and diagnostic compositions.

Claims (11)

1. A purified polypeptide capable of forming antigen binding structures with specificity for Rhesus D antigens of the partial DVI phenotype comprising

a V H region having SEQ ID NO: 58 or SEQ ID NO: 62, and

a V L region.

2. The polypeptide of claim 1 , wherein the polypeptide is an antigen binding Fab fragment.

3. The polypeptide of claim 1 , wherein the polypeptide is an immunoglobulin specific for a Rhesus D antigen.

4. The polypeptide of claim 3 , wherein the immunoglobulin comprises at least one defined isotype selected from the group consisting of IgG1, IgG2, IgG3, and IgG4.

5. A recombinant polynucleotide which encodes the polypeptide of claim 1 .

6. A composition comprising at least one polypeptide of claim 1 and a pharmaceutically acceptable carrier.

7. A composition comprising at least one immunoglobulin of claim 3 and a pharmaceutically acceptable carrier.

8. A diagnostic composition for Rhesus D typing comprising at least one polypeptide of claim 1 .

9. A diagnostic composition for Rhesus D typing comprising at least one immunoglobulin of claim 3 .

Assignments (1)
CHANGE OF NAME Recorded Aug 24, 2010
From: ZLB BEHRING AG
To: CSL BEHRING AG
Reel/Frame 024879/0077 →
Priority Claims (1)
EP 96810421 · Jun 24, 1996 · regional
Continuity (2)
Continuation 0914744300
Related Publication 20060165694A1 · Jul 27, 2006